CervoMed Inc.
CRVO
$4.09
-$0.15-3.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.53% | -114.15% | -348.36% | -349.69% | -650.10% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 196.51% | -3.48% | 98.33% | 102.72% | 104.00% |
| Change in Net Operating Assets | 762.99% | -49.19% | -264.19% | -415.76% | -68.66% |
| Cash from Operations | -41.86% | -126.21% | -205.51% | -157.07% | -121.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 163.14% | 158.02% | 142.03% | -- | -- |
| Cash from Investing | 163.14% | 158.02% | 142.03% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -90.11% | -90.11% | -90.28% | 5,629.86% | 5,629.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.11% | -90.09% | -92.05% | 316.16% | 316.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -163.32% | 163.17% | -118.04% | 9.98% | -67.39% |